ENTACAPONE COMBI ACTAVIS 125/31.25/200 levodopa/carbidopa/entacapone 125/31.25/200 mg tablet bottle

Land: Ástralía

Tungumál: enska

Heimild: Department of Health (Therapeutic Goods Administration)

Virkt innihaldsefni:

carbidopa monohydrate, Quantity: 33.75 mg (Equivalent: carbidopa, Qty 31.25 mg); entacapone, Quantity: 200 mg; levodopa, Quantity: 125 mg

Fáanlegur frá:

Medis Pharma Pty Ltd

INN (Alþjóðlegt nafn):

carbidopa monohydrate,Entacapone,Levodopa

Lyfjaform:

Tablet, film coated

Samsetning:

Excipient Ingredients: trehalose dihydrate; microcrystalline cellulose; hyprolose; magnesium stearate; powdered cellulose; carmellose sodium; sodium sulfate; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350; lecithin

Stjórnsýsluleið:

Oral

Einingar í pakka:

100 tablets

Gerð lyfseðils:

(S4) Prescription Only Medicine

Ábendingar:

levodopa/carbidopa/entacapone is indicated for the management of patients with Parkinson?s disease who are experiencing motor fluctuations.

Vörulýsing:

Visual Identification: Red, oval, biconvex coated tablet with '125' on one side and 'LEC'on the other side; Container Type: Bottle; Container Material: HDPE; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Leyfisstaða:

Registered

Leyfisdagur:

2013-10-04